BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 214 filers reported holding BEAM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,309,543 | -10.9% | 137,611 | +18.3% | 0.01% | 0.0% |
Q2 2023 | $3,715,373 | +11.6% | 116,360 | +7.0% | 0.01% | 0.0% |
Q1 2023 | $3,330,169 | -6.7% | 108,758 | +19.2% | 0.01% | 0.0% |
Q4 2022 | $3,569,255 | -18.6% | 91,262 | -0.9% | 0.01% | -30.0% |
Q3 2022 | $4,384,000 | +25.6% | 92,061 | +2.0% | 0.01% | +42.9% |
Q2 2022 | $3,491,000 | -32.4% | 90,212 | -0.0% | 0.01% | -22.2% |
Q1 2022 | $5,167,000 | -27.4% | 90,220 | +1.0% | 0.01% | -18.2% |
Q4 2021 | $7,117,000 | +15.2% | 89,326 | +25.8% | 0.01% | +10.0% |
Q3 2021 | $6,179,000 | -21.2% | 71,023 | +16.6% | 0.01% | -23.1% |
Q2 2021 | $7,840,000 | +258.0% | 60,917 | +122.5% | 0.01% | +225.0% |
Q1 2021 | $2,190,000 | +362.0% | 27,380 | +370.9% | 0.00% | +300.0% |
Q4 2020 | $474,000 | – | 5,815 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $189,105,000 | 91.90% |
PATHWAY CAPITAL MANAGEMENT, LP | 37,399 | $2,993,000 | 16.59% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,390 | $17,960,000 | 10.54% |
HSG Holding Ltd | 796,089 | $63,719,000 | 4.73% |
DC Investments Management, LLC | 21,010 | $1,682,000 | 4.17% |
Monashee Investment Management LLC | 268,820 | $21,516,000 | 3.31% |
Redmile Group, LLC | 2,532,523 | $202,703,000 | 2.86% |
HAMILTON LANE ADVISORS LLC | 98,761 | $7,905,000 | 2.58% |
Alphabet Inc. | 640,792 | $51,289,000 | 2.07% |
Casdin Capital, LLC | 818,820 | $65,538,000 | 1.95% |